本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (6565)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2024 (publication date) through Jun 26, 2025
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Hepatology
ISSN
1948-5182
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cao WH, Zhang YQ, Li XX, Zhang ZY, Li MH. Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients. World J Hepatol 2024; 16(10): 1158-1168 [PMID: 39474576 DOI: 10.4254/wjh.v16.i10.1158] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v16/i10/1158.htm |
| 编号 | Citing Articles |
| 1 |
Yuyao Yuan, Donghao Yin, Xuemeng Yang, Di Liu, Hui Shan, Juan Luo, Xiuhui Li, Yuxin Yin. Plasma lipidomic analysis reveals disruption of ether phosphatidylcholine biosynthesis and facilitates early detection of hepatitis B-related hepatocellular carcinoma. Lipids in Health and Disease 2025; 24(1) doi: 10.1186/s12944-025-02475-z
|
| 2 |
Christina Karampera, Antonio D'Alessio. Not So Quiet on the Viral Front: Low‐Level HBV Viraemia Undermines Immunotherapy in HCC. Liver International 2025; 45(6) doi: 10.1111/liv.70140
|